ONCSQ (OncoSec Medical) Gross Margin %: 0.00% (As of Jan. 2023)

What is OncoSec Medical Gross Margin %?

OncoSec Medical ONCSQ -99.00% Gross Margin % is 0.00% as of Jan. 2023.

Gross Margin % is calculated as gross profit divided by its revenue. OncoSec Medical's Gross Profit for the three months ended in Jan. 2023 was $0.00 Mil. OncoSec Medical's Revenue for the three months ended in Jan. 2023 was $0.00 Mil. Therefore, OncoSec Medical's Gross Margin % for the quarter that ended in Jan. 2023 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

The historical rank and industry rank for OncoSec Medical's Gross Margin % or its related term are showing as below:

ONCSQ's Gross Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: 60.92
* Ranked among companies with meaningful Gross Margin % only.

OncoSec Medical had a gross margin of N/A% for the quarter that ended in Jan. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for OncoSec Medical was 0.00% per year.

OncoSec Medical (OTCPK:ONCSQ) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

OncoSec Medical had a gross margin of N/A% for the quarter that ended in Jan. 2023 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

OncoSec Medical Gross Margin % Related Terms

OncoSec Medical Gross Margin % Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Gross Margin % Chart

OncoSec Medical Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Gross Margin %

Get a 7-Day Free Trial

0.00

OncoSec Medical Quarterly Data
	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23
Gross Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ONCSQ vs NOVNQ, USRM, VRTX: Gross Margin % Comparison

For the Biotechnology subindustry, OncoSec Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSec Medical Gross Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoSec Medical's Gross Margin % distribution charts can be found below:

* The bar in red indicates where OncoSec Medical's Gross Margin % falls into.

Save Embed

OncoSec Medical Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

OncoSec Medical's Gross Margin for the fiscal year that ended in Jul. 2022 is calculated as

Gross Margin % (A: Jul. 2022 )	=	Gross Profit (A: Jul. 2022 )	/	Revenue (A: Jul. 2022 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

OncoSec Medical's Gross Margin for the quarter that ended in Jan. 2023 is calculated as

Gross Margin % (Q: Jan. 2023 )	=	Gross Profit (Q: Jan. 2023 )	/	Revenue (Q: Jan. 2023 )
	=	0	/	0
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0 - 0)	/	0
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →

What does a Gross Margin % of 0.00% mean?

OncoSec Medical (ONCSQ) has a Gross Margin % of 0.00% as of Jan. 2023. Gross margin is the ratio of total gross profit to net sales. View historical data on OncoSec Medical and its competitors.

Is OncoSec Medical's Gross Margin % too high?

OncoSec Medical's current Gross Margin % is 0.00%.

How does OncoSec Medical's Gross Margin % compare to NOVNQ and USRM?

OncoSec Medical's Gross Margin % of 0.00% can be compared against companies in the Biotechnology industry. The industry median Gross Margin % is 60.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Gross Margin % for a Biotechnology company?

The median Gross Margin % among Biotechnology companies is 60.92, based on 737 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Gross Margin % mean?

A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on OncoSec Medical and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OncoSec Medical's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is OncoSec Medical stock overvalued right now?

OncoSec Medical (ONCSQ) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Gross Margin % calculated?

Gross Margin % is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Gross Margin % is 0.00% as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Industry Healthcare Biotechnology

Comparable Companies NOVNQ USRM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB RPRX

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021

Website https://www.oncosec.com

OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.